Trending Now
Business
Judge Dismisses Another Opioid Lawsuit
The number of accidental deaths related to opioids and the number of people addicted to them have been on the rise. Some believe such...
Micron: Is The Catbird Seat Heating Up?
Micron (MU) reported Q2 revenue of $7.35 billion and eps of $2.82. The company beat on revenue by $70 million and beat on eps...
Lifestyle today
Entertainment
Teva Maneuvers To Match 30% Discounts For Generic Copaxone
The major question surrounding Teva (TEVA) is how much Mylan's (MYL) generic Copaxone will impact Copaxone sales. The answer to that question began to...
Endo: TRT Liability Settlement Clears Path For Explosive Growth
Endo Pharmaceuticals (OTCPK:ENDO) recently announced it has executed a master settlement agreement allowing for the resolution of all the company's known testosterone replacement therapy...
Will Judge David Carter Force Valeant, Ackman To Disgorge $2 Billion Insider Trading Profits?
Valeant (VRX) and Pershing Square's (PSHZF) Bill Ackman announced they settled the Allergan (AGN) insider trading case for $290 million. A court is now...
The Story King Charles, CNN Are Afraid Of
A few months ago the Shock Exchange heard about a new show on CNN featuring Charles Barkley and Gayle King. Barkley has...
How Moody’s And S&P Missed Valeant’s Insolvency
The decade after the Financial Crisis has been a boom period, at least on the surface. The Dow Jones Industrial Average (DIA) shot past...
Did Maria Chappelle-Nadal’s Impassioned Speech Move Biden To Hire Symone Sanders?
Joe Biden recently added his name to the growing list of democratic hopefuls looking to defeat President Trump. Biden recently hired Symone Sanders as...
Goldman Sachs, Credit Suisse Battle With ‘Shock Exchange’ Over Teva
Generics drug giant Teva has been reeling since Mylan won approval to offer a generic version of blockbuster multiple sclerosis drug Copaxone. The drug...
Oracle Earnings Preview
Oracle (ORCL) reports quarterly earnings Thursday. Analysts expect revenue of $9.6 billion and EPS of $0.84. The revenue estimate implies flat growth sequentially.
Growth Appears...























































































































